[Propositions for perinatal care at extremely low gestational ages - Working group on "Extremely low gestational ages" for SFMP, CNGOF, and SFN].

Propositions sur la prise en charge en cas d’extrême prématurité – Le groupe de travail « Extrême Prématurité » pour la SFMP, le CNGOF et la SFN.
Extremely preterm births French propositions Perinatal management Prise en charge périnatale Propositions françaises Prématurité extrême

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 7 10 2020
medline: 25 11 2021
entrez: 6 10 2020
Statut: ppublish

Résumé

International literature suggests that active perinatal management at extremely low gestational ages improves survival without increasing the risk of impairment in survivors, compared to less active management. Although these results are limited to a small number of countries, they question current practices in France. New propositions on perinatal management of extremely preterm infants have carried out by the French Society of Perinatal Medicine, the French Society of Neonatology and the National College of French Obstetricians and Gynecologists. This group was set up in 2015 on the initiative of the professional societies and in collaboration with parents' and users' associations. The work was based on a review of the literature on the prognosis of extremely preterm children, as well as on recommendations by European societies. Based on this information, a text was produced, submitted to all members of the working group and definitively validated in April 2019. This text offers a decision-making guideline for the management at extremely low gestational ages. Its principles are: the administration of steroids independently of management (resuscitation or comfort care); a prognostic evaluation and a collegial decision, outside the context of the emergency; a consensus on the information to be given to parents before going to inform them and gather their opinion. These new propositions will contribute to modifying perinatal care at extremely low gestational ages in France.

Identifiants

pubmed: 33022445
pii: S2468-7189(20)30278-6
doi: 10.1016/j.gofs.2020.09.021
pii:
doi:

Types de publication

Practice Guideline Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

850-857

Investigateurs

C Bouvard (C)
A Evrard (A)
P Jabert (P)
I de Mezerac (I)

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

P-Y Ancel (PY)

Paris, Société française de médecine périnatale, 75008 Paris, France. Electronic address: pierre-yves.ancel@inserm.fr.

G Breart (G)

Paris, Société française de médecine périnatale, 75008 Paris, France.

H Bruel (H)

Le Havre, Société française de médecine périnatale, Société française de néonatologie, 76600 Le Havre, France.

T Debillon (T)

Grenoble, Société française de médecine périnatale, Société française de néonatologie, 38000 Grenoble, France.

C D'Ercole (C)

Marseille, Société française de médecine périnatale, Collège national des gynécologues et obstétriciens français, 13000 Marseille, France.

P Deruelle (P)

Strasbourg, Collège national des gynécologues obstétriciens français, 67000 Strasbourg, France.

M Dreyfus (M)

Caen, Société française de médecine périnatale, Collège national des gynécologues et obstétriciens français, 14000 Caen, France.

L Foix-L'Helias (L)

Paris, Société française de néonatologie, 75008 Paris, France.

F Goffinet (F)

Paris, Société française de médecine périnatale, Collège national des gynécologues et obstétriciens français, 75008 Paris, France.

P-H Jarreau (PH)

Paris, Société française de néonatologie, 75008 Paris, France.

P Kuhn (P)

Strasbourg, Société française de néonatologie, 67000 Strasbourg, France.

B Langer (B)

Strasbourg, Société française de médecine périnatale, Collège national des gynécologues et obstétriciens français, 67000 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH